Trimetazidine (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Trimetazidine" in English language version.

refsWebsite

Global rank English rank

11nih.gov

4^th place

9doi.org

2^nd place

4semanticscholar.org

11^th place

8^th place

3web.archive.org

1^st place

2cnn.com

28^th place

26^th place

2apnews.com

129^th place

89^th place

1drugs.com

399^th place

333^rd place

1europa.eu

68^th place

117^th place

1gla.ac.uk

2,948^th place

1,879^th place

1acs.org

1,248^th place

1,104^th place

1wada-ama.org

9,542^nd place

8,313^th place

1sportsintegrityinitiative.com

low place

1yahoo.com

38^th place

40^th place

1swimmingworldmagazine.com

6,159^th place

3,833^rd place

1cbc.ca

115^th place

82^nd place

1swimswam.com

4,729^th place

2,965^th place

1reuters.com

49^th place

47^th place

1usatoday.com

41^st place

34^th place

1bbc.com

20^th place

30^th place

1tas-cas.org

7,819^th place

5,731^st place

1olympics.com

637^th place

519^th place

1popsci.com

2,941^st place

2,021^st place

1nytimes.com

7^th place

1washingtonpost.com

34^th place

27^th place

1vice.com

175^th place

137^th place

1x.com

low place

acs.org

cen.acs.org

Howes, Laura (17 February 2022). "What is trimetazidine and why is it banned in Olympic competition?". cen.acs.org. Retrieved 2022-02-19. Trimetazidine (TMZ) is the generic name for the chemical that acts as a vasodilator and was discovered over 50 years ago (1970s). TMZ is commonly prescribed in Europe and Russia where it is taken as a pill or in delayed-release tablets to treat angina as well as vertigo, tinnitus, and certain visual disturbances. Since 2014, WADA has classed TMZ as a prohibited substance.

apnews.com

"Olympic medals in team figure skating delayed by legal issue". AP News. 9 February 2022. Retrieved 9 February 2022.
Ellingworth J, Dunbar G (2022-02-14). "Russian skater Kamila Valieva cleared to compete at Olympics". AP NEWS. Retrieved 2022-02-14.

bbc.com

Thompson A (February 11, 2022). "Valieva failed drugs test confirmed". BBC Sport.

cbc.ca

"FINA reduces doping ban for world champ Madisyn Cox". CBC. 2018-09-03. Retrieved 2018-09-03.

cnn.com

Ritchie H, Ramsay G (10 February 2022). "Trimetazidine: Drug banned by WADA makes 'your heart work more efficiently'". CNN. CNN. Retrieved 10 February 2022.
Ritchie H, Watson A, Regan H (11 February 2022). "Russian anti-doping agency allowed Kamila Valieva to compete in Olympics despite failed drug test". CNN.

doi.org

Ferrari R, Ford I, Fox K, Challeton JP, Correges A, Tendera M, et al. (September 2020). "Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial" (PDF). The Lancet. 396 (10254): 830–838. doi:10.1016/S0140-6736(20)31790-6. PMID 32877651. S2CID 221365071.
Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, et al. (September 2006). "A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure". J. Am. Coll. Cardiol. 48 (5): 992–998. doi:10.1016/j.jacc.2006.03.060. PMID 16949492. S2CID 46184701.
Tuunanen H, Engblom E, Naum A, Någren K, Scheinin M, Hesse B, et al. (September 2008). "Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy". Circulation. 118 (12): 1250–1258. doi:10.1161/CIRCULATIONAHA.108.778019. PMID 18765391. S2CID 23580702.
Khanra S, Reddy P, Giménez-Palomo A, Park CH, Panizzutti B, McCallum M, et al. (August 2023). "Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine". Molecular Psychiatry. 28 (8): 3231–3242. doi:10.1038/s41380-023-02134-8. PMC 10618096. PMID 37386057.
Burke MG, Faber K (September 2012). "A plea for thresholds, i.e., maximal allowed levels for prohibited substances, to prevent questionable doping convictions". Science & Justice. 52 (3): 199–201. doi:10.1016/j.scijus.2012.02.002. PMID 22841145.
Ciapponi A, Pizarro R, Harrison J (2017). Ciapponi A (ed.). "Trimetazidine for stable angina". Cochrane Database Syst Rev. 2017 (3): CD003614. doi:10.1002/14651858.CD003614.pub3. PMC 6464521. PMID 16235330. (Retracted)|This review series was withdrawn because the authors did not opt to continue updating it; the journal has not "withdrawn" it in the usual sense
Fragasso G, Rosano G, Baek SH, Sisakian H, Di Napoli P, Alberti L, et al. (March 2013). "Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: results from an international multicentre retrospective cohort study". International Journal of Cardiology. 163 (3): 320–325. doi:10.1016/j.ijcard.2012.09.123. PMID 23073279.
Kantor PF, Lucien A, Kozak R, Lopaschuk GD (March 2000). "The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase". Circ. Res. 86 (5): 580–588. doi:10.1161/01.RES.86.5.580. PMID 10720420.
Stanley WC, Marzilli M (April 2003). "Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine". Fundam Clin Pharmacol. 17 (2): 133–145. doi:10.1046/j.1472-8206.2003.00154.x. PMID 12667223. S2CID 10407498.

drugs.com

"Trimetazidine". Drugs.com.

europa.eu

ema.europa.eu

"European Medicines Agency recommends restricting use of trimetazidine-containing medicines" (PDF). Press release. European Medicines Agency. 2012-06-12. Archived from the original (PDF) on 2013-04-06. Retrieved 2012-06-24.

gla.ac.uk

eprints.gla.ac.uk

Ferrari R, Ford I, Fox K, Challeton JP, Correges A, Tendera M, et al. (September 2020). "Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial" (PDF). The Lancet. 396 (10254): 830–838. doi:10.1016/S0140-6736(20)31790-6. PMID 32877651. S2CID 221365071.

nih.gov

pubmed.ncbi.nlm.nih.gov

Ferrari R, Ford I, Fox K, Challeton JP, Correges A, Tendera M, et al. (September 2020). "Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial" (PDF). The Lancet. 396 (10254): 830–838. doi:10.1016/S0140-6736(20)31790-6. PMID 32877651. S2CID 221365071.
Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, et al. (September 2006). "A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure". J. Am. Coll. Cardiol. 48 (5): 992–998. doi:10.1016/j.jacc.2006.03.060. PMID 16949492. S2CID 46184701.
Tuunanen H, Engblom E, Naum A, Någren K, Scheinin M, Hesse B, et al. (September 2008). "Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy". Circulation. 118 (12): 1250–1258. doi:10.1161/CIRCULATIONAHA.108.778019. PMID 18765391. S2CID 23580702.
Khanra S, Reddy P, Giménez-Palomo A, Park CH, Panizzutti B, McCallum M, et al. (August 2023). "Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine". Molecular Psychiatry. 28 (8): 3231–3242. doi:10.1038/s41380-023-02134-8. PMC 10618096. PMID 37386057.
Burke MG, Faber K (September 2012). "A plea for thresholds, i.e., maximal allowed levels for prohibited substances, to prevent questionable doping convictions". Science & Justice. 52 (3): 199–201. doi:10.1016/j.scijus.2012.02.002. PMID 22841145.
Ciapponi A, Pizarro R, Harrison J (2017). Ciapponi A (ed.). "Trimetazidine for stable angina". Cochrane Database Syst Rev. 2017 (3): CD003614. doi:10.1002/14651858.CD003614.pub3. PMC 6464521. PMID 16235330. (Retracted)|This review series was withdrawn because the authors did not opt to continue updating it; the journal has not "withdrawn" it in the usual sense
Fragasso G, Rosano G, Baek SH, Sisakian H, Di Napoli P, Alberti L, et al. (March 2013). "Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: results from an international multicentre retrospective cohort study". International Journal of Cardiology. 163 (3): 320–325. doi:10.1016/j.ijcard.2012.09.123. PMID 23073279.
Kantor PF, Lucien A, Kozak R, Lopaschuk GD (March 2000). "The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase". Circ. Res. 86 (5): 580–588. doi:10.1161/01.RES.86.5.580. PMID 10720420.
Stanley WC, Marzilli M (April 2003). "Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine". Fundam Clin Pharmacol. 17 (2): 133–145. doi:10.1046/j.1472-8206.2003.00154.x. PMID 12667223. S2CID 10407498.

ncbi.nlm.nih.gov

Khanra S, Reddy P, Giménez-Palomo A, Park CH, Panizzutti B, McCallum M, et al. (August 2023). "Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine". Molecular Psychiatry. 28 (8): 3231–3242. doi:10.1038/s41380-023-02134-8. PMC 10618096. PMID 37386057.
Ciapponi A, Pizarro R, Harrison J (2017). Ciapponi A (ed.). "Trimetazidine for stable angina". Cochrane Database Syst Rev. 2017 (3): CD003614. doi:10.1002/14651858.CD003614.pub3. PMC 6464521. PMID 16235330. (Retracted)|This review series was withdrawn because the authors did not opt to continue updating it; the journal has not "withdrawn" it in the usual sense

nytimes.com

Longman J, Kolata G, Tumin R (11 February 2022). "What Is Trimetazidine, and Would It Have Helped Kamila Valieva of Russia?". The New York Times.

olympics.com

"IOC EB decides no medal ceremonies following CAS decision on the case of ROC skater". International Olympic Committee.

popsci.com

Kiefer P (February 16, 2022). "Kamila Valieva's 'doping' drug probably doesn't give athletes an edge". PopSci.

reuters.com

Tétrault-Farber G, Axon I, Grohmann K (9 February 2022). "Figure skating-Russian media say teen star tested positive for banned drug". Reuters. Retrieved 9 February 2022.

semanticscholar.org

api.semanticscholar.org

Ferrari R, Ford I, Fox K, Challeton JP, Correges A, Tendera M, et al. (September 2020). "Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial" (PDF). The Lancet. 396 (10254): 830–838. doi:10.1016/S0140-6736(20)31790-6. PMID 32877651. S2CID 221365071.
Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, et al. (September 2006). "A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure". J. Am. Coll. Cardiol. 48 (5): 992–998. doi:10.1016/j.jacc.2006.03.060. PMID 16949492. S2CID 46184701.
Tuunanen H, Engblom E, Naum A, Någren K, Scheinin M, Hesse B, et al. (September 2008). "Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy". Circulation. 118 (12): 1250–1258. doi:10.1161/CIRCULATIONAHA.108.778019. PMID 18765391. S2CID 23580702.
Stanley WC, Marzilli M (April 2003). "Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine". Fundam Clin Pharmacol. 17 (2): 133–145. doi:10.1046/j.1472-8206.2003.00154.x. PMID 12667223. S2CID 10407498.

sportsintegrityinitiative.com

"Chinese swimmer Sun Yang is being falsely punished". Sports Integrity Initiative. 2020-03-19. Retrieved 2022-02-19.

swimmingworldmagazine.com

Selthoffer S (2 December 2014). "The Sun Yang Doping Case: Chapter Two of an Olympic Champion". Swimming World.

swimswam.com

Gibbs R (2018-08-31). "Madisyn Cox's Suspension Reduced to Six Months after Trimetazidine Detected in Multivitamin". SwimSwam. Retrieved 2018-09-03.

tas-cas.org

"CAS Ad Hoc Media Release" (PDF).

usatoday.com

Brennan C (9 February 2022). "Positive drug test by Russian Kamila Valieva has forced a delay of Olympic team medals ceremony". USA Today.

vice.com

"Why Would a 15-Year-Old Star Figure Skater Take Heart Medicine?". www.vice.com. 17 February 2022. Retrieved 2022-05-27.

wada-ama.org

"World Anti-Doping Code International Standard Prohibited List" (PDF). World Anti-Doping Agency. 1 January 2022.

washingtonpost.com

Garcia-Roberts G, Abutaleb Y. "What to know about Trimetazidine, the drug at the center of the Olympic doping case". Washington Post. 0190-8286. Archived from the original on 2022-02-11. Retrieved 2022-02-14.

web.archive.org

"European Medicines Agency recommends restricting use of trimetazidine-containing medicines" (PDF). Press release. European Medicines Agency. 2012-06-12. Archived from the original (PDF) on 2013-04-06. Retrieved 2012-06-24.
Garcia-Roberts G, Abutaleb Y. "What to know about Trimetazidine, the drug at the center of the Olympic doping case". Washington Post. 0190-8286. Archived from the original on 2022-02-11. Retrieved 2022-02-14.
@aiu_athletics (July 16, 2022). "The AIU has provisionally suspended…" (Tweet). Archived from the original on 2022-07-16. Retrieved 2023-05-27 – via Twitter.

x.com

@aiu_athletics (July 16, 2022). "The AIU has provisionally suspended…" (Tweet). Archived from the original on 2022-07-16. Retrieved 2023-05-27 – via Twitter.

yahoo.com

es.sports.yahoo.com

"Sun Yang, el chico malo de la natación que gana todo pero al que nadie quiere". yahoo.es. 22 July 2019.